These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38789025)

  • 1. Establishment of a novel cellular model for Alzheimer's disease in vitro studies.
    El-Araby RE; Wasif K; Johnson R; Tu Q; Aboushousha T; Zhu ZX; Chen J
    Exp Neurol; 2024 Aug; 378():114820. PubMed ID: 38789025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappa β as a therapeutic target for Alzheimer's disease.
    Jha NK; Jha SK; Kar R; Nand P; Swati K; Goswami VK
    J Neurochem; 2019 Jul; 150(2):113-137. PubMed ID: 30802950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer's disease.
    Kong F; Jiang X; Wang R; Zhai S; Zhang Y; Wang D
    J Neuroinflammation; 2020 Oct; 17(1):305. PubMed ID: 33059746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR34 Knockdown Relieves Cognitive Deficits and Suppresses Neuroinflammation in Alzheimer's Disease via the ERK/NF-κB Signal.
    Lin LL; Song GJ; Zhang H; Yin Y; Xin SM; Ding L; Li Y
    Neuroscience; 2023 Sep; 528():129-139. PubMed ID: 37557947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXW11 deletion alleviates Alzheimer's disease by reducing neuroinflammation and amyloid-β plaque formation via repression of ASK1 signaling.
    Sun J; Qin X; Zhang X; Wang Q; Zhang W; Wang M
    Biochem Biophys Res Commun; 2021 Apr; 548():104-111. PubMed ID: 33640602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
    Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H
    PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
    J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
    Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S
    J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
    Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
    Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD).
    Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer's disease.
    Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):554-64. PubMed ID: 23276558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal deficiency of p38α-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models.
    Schnöder L; Gasparoni G; Nordström K; Schottek A; Tomic I; Christmann A; Schäfer KH; Menger MD; Walter J; Fassbender K; Liu Y
    FASEB J; 2020 Jul; 34(7):9628-9649. PubMed ID: 32475008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
    Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
    Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.